SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

2.580

+0.430 (20.00%)

At close: Sep 17, 2025, 4:00 PM EDT

2.510

-0.070 (-2.71%)

Pre-market: Sep 18, 2025, 7:34 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Immunotheraphies	2.24M	Log In	Log In	Log In
Immunotheraphies Growth	-90.63%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	2.24M	Log In	Log In	Log In
United States Growth	-90.63%	Log In	Log In	Log In